Young Man in New Zealand Dies of Myocarditis 12 Days After Getting Pfizer COVID Biologic

by TRV Staff

Published December 28, 2021 | Vaccination, Risk & Failure Reports

A 26-year-old man in Dunedin, New Zealand died on Nov. 17, 2021 unexpectedly, 12 days after getting the first dose of Pfizer/BioNTech’s experimental messenger RNA (mRNA) BNT162b2 (also known as “Comirnaty”) biologic for COVID-19. Rory James Nairn was vaccinated on Nov. 5 and reportedly began to feel heart palpations or “flutters” a few hours after the shot The palpations continued for several days until he and his fiancée, Ashleigh Wilson, decided to go to the hospital for “reassurance.”^{1 2}

“Within moments, Rory went into cardiac arrest and died instantly in our home,” Wilson said. “We were about to leave for the hospital and he was in the toilet and I heard a thud. He had fallen, his body was blocking the door, his full weight was against it and I couldn’t get it open. I could just see him through a

crack in the door, I could see that he was gone.” Paramedics arrived at Nairn’s home and tried to revive him, but after 40 minutes Nairn was declared dead.^{1 2}

Nairn had no pre-existing medical conditions and was physically active according to Wilson. “He played rugby, went diving and hunting on the weekends, worked hard as a plumber,” she said.²

According to a statement from New Zealand’s COVID-19 Vaccine Independent Safety Monitoring Board (CV-ISMB), “Preliminary information from the post-mortem examination has identified myocarditis as the probable cause of death. … With the current available information, the Board has considered that the myocarditis (inflammation of the heart muscle) was probably due to vaccination in this individual.”^{1 3 4 5}

Other Deaths in New Zealand Possibly Linked to Pfizer COVID Biologic

Nairn’s death follows the death of a woman in New Zealand in August after taking the second dose of  BNT162b2. That was believed to be the first death in New Zealand linked to Pfizer/BioNTech shot. The CV-ISMB stated that the myocarditis suffered by the woman “was probably due to vaccination.”^5 6

In a press release, New Zealand’s Ministry of Health stated:

This is the first case in New Zealand where a death in the days following vaccination has been linked to the Pfizer COVID-19 vaccine. While CARM has received other reports of deaths in someone recently vaccinated, none are considered related to vaccination. Details of these cases have been published on the Medsafe website.⁷

The CV-ISMB said that it is investigating two other cases of individuals in New Zealand who died of possible myocarditis after receiving the Pfizer/BioNTech BNT162b2 biologic. One case involved a 13-year-old boy and the other a man in his 60s.^{5 8}

FDA Warns of Heart Inflammation Risks to Moderna and Pfizer COVID Biologics

On June 25, 2021, the U.S. Food and Drug Administration (FDA) added a warning about both the risk of myocarditis and pericarditis (inflammation of the membrane surrounding the heart) to the package labels of Pfizer’s BNT162b2 product and Moderna/NIAID’s experimental mRNA-1273 (or “Spikevax”) biologic. The FDA’s decision followed a determination by U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) on June 23 that there was a “likely association” between reported cases of myocarditis and pericarditis following vaccination with the two products.^{9 10}

Moderna/NIAID COVID Shot Causes More Heart Inflammation Than Pfizer/BioNTech Shot

A study by Denmark’s Statens Serum Institute published on Dec. 16 in the BMJ found that Moderna’s mRNA-1273 is up to four times more likely to cause myocarditis or pericarditis than Pfizer/BioNTech’s BNT162b2.¹¹ The study states:

Vaccination with mRNA-1273 (Moderna’s vaccine) was associated with a significantly increased risk of myocarditis or myopericarditis in the Danish population. …In general, the rate of myocarditis or myopericarditis was about threefold to fourfold higher for mRNA-1273 (Moderna) vaccination than that for BNT162b2 (Pfizer-BioNTech) vaccination.^{11 12}

---

If you would like to receive an e-mail notice of the most recent articles published in The Vaccine Reaction each week, click here

Click here to view References: